NRx Pharmaceuticals (NRXP) announced that it has entered into a binding agreement for a registered direct offering of its common stock with ...

Short interest in NRX Pharmaceuticals Inc (NASDAQ:NRXP) increased during the last reporting period, rising from 643.00K to 1.21M. This put 11.81% of the company's publicly available shares short.

NRx Pharmaceuticals shares gained after the company said it would buy California psychiatry clinic Kadima Neuropsychiatry Institute. The stock rose Thursday to $2.92, reaching a six-month high ...